Niche preclinical focus Specializes in preclinical efficacy evaluation in non-human primate models, offering high-value translational data for CNS and pain therapies, which can be leveraged to strengthen late-stage development discussions with big pharma.

Strategic partnerships Recent collaboration with Astrocyte Pharmaceuticals on stroke models highlights openness to co-development and external partnerships, presenting a pathway to joint studies or sponsored research for potential collaborators.

Moderate scale agility Small to mid-sized operation (11-50 employees) combined with revenue in the low single-digit millions suggests a nimble partner capable of fast project starts and customized service agreements, appealing to biotech firms seeking dedicated CRO support.

Pain and CNS expertise Focused assessment areas include chemotherapy-induced neuropathic pain, osteoarthritis, and cerebral ischemia, enabling targeted proposals to companies developing analgesics, neuroprotectants, or stroke therapies.

Technology and tools Utilizes widely adopted platforms (Google Cloud, Google Workspace, Sentry) and web presence tools (Wix, WordPress), indicating accessible IT infrastructure to support collaborative projects, data sharing, and secure collaboration with sponsors.